The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BACKGROUND: Diabetic coronary heart disease (DCHD), the main macrovascular complication of type 2 diabetes mellitus (T2DM), is greatly harmful to T2DM patients. Traditional Chinese medicine (TCM) is an alternative and effective therapy to delay the development of macrovascular diseases, but the exis...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Metab Syndr Obes
主要な著者: Wang, Lexun, Xiang, Lei, Piao, Shenghua, Gong, Xiao, Zhou, Wanxing, Feng, Weixun, Li, Huilin, Li, Leyu, Wei, Aisheng, Zhu, Qing, Rong, Xianglu, Guo, Jiao
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2021
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214008/
https://ncbi.nlm.nih.gov/pubmed/34163193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S309419
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料